Crucell, Sanofi mix it up with rabies cocktail deal
Dutch firm Crucell last week announced that it has entered into an agreement with vaccine specialist Sanofi Pasteur for its next generation rabies antibody cocktail.
Dutch firm Crucell last week announced that it has entered into an agreement with vaccine specialist Sanofi Pasteur for its next generation rabies antibody cocktail.
WuXi PharmaTech, China's contract research titan, has orchestrated its first acquisition, gaining biologics capabilities and a base in the US.
The pharma industry spends almost twice as much promoting its drugs as it does trying to develop them, according to a new study.
Although India 'has carved out a significant portion of the world pharma pie', an enormous change in mindset is needed if the country is to become a global pharmaceutical hub, according to a new report from KPMG.